Day: December 14, 2020
Categories Parkinson's Disease

Active Pharmaceutical Ingredients (API) Market Trends, Regulations And Competitive Landscape

The study is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails.  This report analyses the global market for active pharmaceutical ingredients for the period from 2012 to 2020. The market has been analyzed on the basis of […]

Read More
Categories Parkinson's Disease

Research with Academics in BITS Pilani

Without research work, it is impossible to learn and match the technological expertise of the global standards. We are already lacking behind in the new innovations and researches as compared to other developing countries. This effort will only be realized when the institutions will take the research work as of utmost importance. While doing higher […]

Read More
HealthClot Feature Image
Categories Uncategorized

Acibadem Continues Breakthrough Pancreatic Cancer Treatments in Turkey

Acibadem Continues Breakthrough Pancreatic Cancer Treatments in Turkey In the interview, Prof. Ceyhan, a doctor at Acibadem Maslak and Altunizade Hospital, reviewed treatment methodologies available for cancer patients afflicted with one of the most dangerous forms of the disease. Worldwide, nearly 250,000 new patients were diagnosed with malignant tumors affecting the pancreas in 2018. Due […]

Read More
Categories Multiple Myeloma

Cipla spurts on settling litigation with Celgene Corp for cancer drug Revlimid

Cipla spurts on settling litigation with Celgene Corp for cancer drug Revlimid Cipla rose 3.70% to Rs 783.85 after the drug major announced the settlement of its litigation with Celgene Corporation relating to patents for Revlimid (lenalidomide). In the US, Revlimid (lenalidomide) in combination with dexamethasone is indicated for the treatment of patients with multiple […]

Read More
Categories Multiple Myeloma

Analysts Expect Sutro Biopharma, Inc. (NASDAQ:STRO) Will Announce Quarterly Sales of $12.60 …

Analysts Expect Sutro Biopharma, Inc. (NASDAQ:STRO) Will Announce Quarterly Sales of $12.60 … Equities analysts expect that Sutro Biopharma, Inc. (NASDAQ:STRO) will post $12.60 million in sales for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Sutro Biopharma’s earnings, with estimates ranging from $7.00 million to $19.54 million. Sutro Biopharma reported […]

Read More